Modular Approaches to Lankacidin Antibiotics
Lingchao Cai1,2, Yanmin Yao2, Seul Ki Yeon2
1Jiangsu Provincial Key Lab for the Chemistry and Utilization of Agro-Forest Biomass, Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Jinagsu Key Lab of Biomass-Based Green Fuels and Chemicals, Nanjing Forestry University, Nanjing, 210037 Jiangsu, China.
Journal of the American Chemical Society
|August 14, 2020
Summary
Synthetic chemistry advances access to novel lankacidin antibiotics. This study corrects structures of known compounds and creates new derivatives with potential antimicrobial activity.
Area of Science:
- Natural Products Chemistry
- Synthetic Organic Chemistry
- Medicinal Chemistry
Background:
- Lankacidins are polyketide natural products from *Streptomyces spp.* with antimicrobial potential.
- Their complex structures and instability pose challenges for synthesis and modification.
- Previous structural assignments for some lankacidins were inaccurate.
Purpose of the Study:
- To develop novel synthetic routes for lankacidins.
- To generate structurally diverse lankacidin derivatives for stability and activity.
- To correct and confirm the structures of specific lankacidin natural products.
Main Methods:
- Development of three distinct total synthesis strategies for lankacidins.
- Systematic generation of stereochemical variants of cyclic and acyclic lankacidins.
- Synthesis of C4-methylated lankacidins to enhance chemical stability.
Main Results:
- Successful synthesis of diverse lankacidin analogues, including C4-methylated derivatives.
- Correction of the previously reported structures for 2,18-seco-lankacidinol B and iso-lankacidinol.
- Evaluation of the antibacterial and protein translation inhibitory activities of novel lankacidins.
Conclusions:
- The developed synthetic routes provide access to new lankacidin structural variations.
- This work clarifies the structural identity of key lankacidin natural products.
- The generated derivatives offer a platform for developing improved antimicrobial agents.
Related Concept Videos
Combined Effects of Drugs: Synergism
6.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.6K
Cytoskeletal Proteins in Bacteria
4.0K
Bacterial cells were initially considered simple, randomly organized structures lacking a cytoskeleton. However, the discovery of cytoskeleton homologs in bacteria led to the change of this opinion. Bacterial cytoskeletal filaments regulate the cell shape, cell polarity, cell division, and partitioning of plasmids during cell division. It was later discovered that bacterial cytoskeletal proteins, mainly actin and tubulin homologs, are diverse compared to their eukaryotic counterparts. On the...
4.0K
Cooperative Allosteric Transitions
8.5K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.5K
Ligand Binding and Linkage
5.3K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.3K


